Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches

Coronavirus disease 2019 (Covid-19), caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can range in severity from asymptomatic to severe/critical disease. SARS-CoV-2 uses angiotensin-converting enzyme 2 to infect cells leading to a strong inflammatory resp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Immunotargets Ther
Autors principals: Hasan, Amal, Al-Ozairi, Ebaa, Al-Baqsumi, Zahraa, Ahmad, Rasheed, Al-Mulla, Fahd
Format: Artigo
Idioma:Inglês
Publicat: Dove 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7955763/
https://ncbi.nlm.nih.gov/pubmed/33728277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S280706
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars